Page last updated: 2024-08-26

3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Cancer of Prostate

3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Botto, JM; Dal Farra, C; Mazella, J; Navarro, V; Sarret, P; Vincent, JP1

Other Studies

1 other study(ies) available for 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate and Cancer of Prostate

ArticleYear
Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.
    International journal of cancer, 2001, May-15, Volume: 92, Issue:4

    Topics: Animals; Cell Membrane; CHO Cells; Cholic Acids; Colonic Neoplasms; Cricetinae; Drug Resistance, Neoplasm; Electrophoresis, Polyacrylamide Gel; Humans; Kinetics; Male; Neurotensin; Pancreatic Neoplasms; Piperidines; Prostatic Neoplasms; Protein Binding; Protein Structure, Tertiary; Receptors, Neurotensin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transfection; Tumor Cells, Cultured

2001